HC Wainwright Forecasts Exodus Movement FY2024 Earnings
Analysts at HC Wainwright issued their FY2024 EPS estimates for Exodus Movement in a report issued on Thursday, January 23rd. HC Wainwright analyst K. Dede forecasts that the company will post ...
HC Wainwright Has Positive View of Precigen FY2024 Earnings
Analysts at HC Wainwright boosted their FY2024 earnings estimates for Precigen in a research report issued to clients and investors on Thursday, January 23rd. HC Wainwright analyst S. Ramakanth now ...
H.C. Wainwright Reaffirms Their Buy Rating on Eton Pharmaceuticals (ETON)
In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Eton Pharmaceuticals (ETON – Research ...
Microbot Medical price target raised to $9 from $7 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Microbot Medical (MBOT) to $9 from $7 and keeps a Buy rating on the shares. The firm believes ...
Hosted on MSN3d
HC Wainwright & Co. Initiates Coverage of Worksport (WKSP) with Buy Recommendation
Fintel reports that on January 23, 2025, HC Wainwright & Co. initiated coverage of Worksport (NasdaqCM:WKSP) with a Buy recommendation. Analyst Price Forecast Suggests 59.38% Upside As of December 23, ...
H.C. Wainwright cuts ALX Oncology target to $5, keeps buy rating
H.C. Wainwright analysts have reduced the price target for ALX Oncology (NASDAQ:ALXO) shares to $5 from the previous $25 ...
manilatimes5d
BTCS Inc. to Participate in Fireside Chat with Blockdaemon hosted by H.C. Wainwright
Charles Allen, CEO of BTCS, stated, " We are thrilled to collaborate with H.C. Wainwright and Freddy to share insights on the ...
ArriVent Biopharma price target raised to $39 from $36 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on ArriVent Biopharma (AVBP) to $39 from $36 and keeps a Buy rating on the ...
Investing5d
H.C. Wainwright Reiterates Buy Rating on Axsome Shares
On Tuesday, H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a price target of $180.00. According to InvestingPro data ...
bovnews4d
Why Did H.C. Wainwright Give Immunic Inc (IMUX) Stock Buy Rating?
Immunic Inc (IMUX) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.98 and touched a low of $0.92 during the day, ...
Investing5d
H.C. Wainwright Reiterates Buy Rating on Axsome Shares
On Tuesday, H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a price target of $180.00. According to InvestingPro data, this ...